WisdomTree Global ex-US Quality Dividend Growth Fund DNL 深 滬
交易中 07-18 11:48:40 美东时间
39.97
-0.116
-0.29%
華盛通- 最 高40.15
- 今 開40.086
- 成交量 5578股
- 最 低 39.97
- 昨 收 40.086
- 總市值 4.96亿
- 52周最高 40.729
- 市盈率 靜 --
- 換手率 0.04%
- 52周最低 31.3768
- 委 比 -98.97%
- 總股本 1240.00万
- 歷史最高 40.729
- 量 比 0.80
- 振 幅 0.45%
- 歷史最低 12.7145
- 每 手 1
- 風險率 1.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Dyno Nobel Announces Cessation of Securities via Buy-Back
Incitec Pivot ( ($AU:DNL) ) has issued an update. Dyno Nobel Limited has announ...
07-17 08:57
Dyno Nobel Limited Updates on Buy-Back Program
Incitec Pivot ( ($AU:DNL) ) has provided an update. Dyno Nobel Limited has anno...
07-17 06:48
Dyno Nobel Reports Director’s Interest Update
Incitec Pivot ( ($AU:DNL) ) has issued an update. Incitec Pivot’s subsidiary, D...
07-10 13:33
Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
Denali Therapeutics announced the FDA's acceptance of its BLA for tividenofusp alfa for Hunter syndrome, granted Priority Review with a PDUFA target date of January 5, 2026. Tividenofusp alfa, an investigational enzyme replacement therapy, is engineered to deliver the missing IDS enzyme across the blood-brain barrier to treat both neurological and physical symptoms of MPS II. The BLA submission is supported by data from the Phase 1/2 study in 47 ...
07-07 12:00
Dyno Nobel Limited Updates on Ongoing Buy-Back Program
Incitec Pivot ( ($AU:DNL) ) has issued an announcement. Dyno Nobel Limited has ...
07-07 06:58
Dyno Nobel Limited Announces Cessation of Securities
The latest announcement is out from Incitec Pivot ( ($AU:DNL) ). Dyno Nobel Lim...
06-25 14:38
Dyno Nobel Limited Updates Director’s Interest Notice
Incitec Pivot ( ($AU:DNL) ) has issued an update. Dyno Nobel Limited, a subsidi...
06-24 12:28
